Search

Your search keyword '"Poggio, F"' showing total 257 results

Search Constraints

Start Over You searched for: Author "Poggio, F" Remove constraint Author: "Poggio, F" Language english Remove constraint Language: english
257 results on '"Poggio, F"'

Search Results

1. Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial

2. Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)

3. VISTA: A Promising Target for Cancer Immunotherapy?

6. 35P SNPs of aromatase gene (CYP19A1) and outcomes of patients with estrogen receptor-positive (ER+) early breast cancer (eBC) treated with aromatase inhibitors (AIs): A multicenter, prospective study

11. Corrigendum to ‘Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)’: [ESMO Open Volume 6, Issue 2, April 2021, 100054]

13. Final results of the tests on the resistive plate chambers for the ALICE muon arm

14. Production of pions, kaons and protons in pp collisions at $\sqrt{s}= 900~\mathrm{GeV}$ with ALICE at the LHC

15. Zero degree Cherenkov calorimeters for the ALICE experiment

16. Charged-particle multiplicity measurement in proton–proton collisions at $\sqrt{s}=7$ TeV with ALICE at LHC

17. Charged-particle multiplicity measurement in proton–proton collisions at $\sqrt{s}=0.9$ and 2.36 TeV with ALICE at LHC

18. First proton–proton collisions at the LHC as observed with the ALICE detector: measurement of the charged-particle pseudorapidity density at $\sqrt{s}=900$  GeV

19. Performance of the zero degree calorimeters for the ALICE experiment

20. The zero degree calorimeters for the ALICE experiment

21. Front-end electronics for the RPCs of the ALICE dimuon trigger

22. Performances of a prototype for the ALICE muon trigger at LHC

23. Beam and ageing tests with a highly–saturated avalanche gas mixture for the ALICE p–p data taking

25. Design and Performance of the ALICE Muon Trigger System

26. Overview on production and first results of the tests on the RPCs for the ALICE dimuon trigger

27. The Neutron Zero Degree Calorimeter for the ALICE experiment

31. Ageing tests on the low-resistivity RPC for the ALICE dimuon arm

33. 118O Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: A randomised, phase III trial of the Gruppo Italiano Mammella

37. 148P Surgery (Sx) of the primary tumour in de novo metastatic breast cancer (BC) patients (pts) is associated with increased survival: A nationwide population-based study by the Belgian Cancer Registry (BCR) and the Belgian Society of Medical Oncology (BSMO)

38. 95TiP Gruppo Italiano Mammella (GIM) 10 – CONSENT: A phase III randomized study comparing concurrent versus sequential administration of adjuvant chemotherapy (CT) and aromatase inhibitors (AIs) in post-menopausal patients (pts) with hormone receptor-positive (HR+) early breast cancer (EBC)

39. 186P - Efficacy of dose-dense (DD) adjuvant chemotherapy (CT) in hormone receptor positive/HER2-negative early breast cancer (BC) patients (pts) according to immunohistochemically (IHC) defined luminal subtypes: An exploratory analysis of the GIM2 trial

44. Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis.

45. Production of pions, kaons and protons in pp collisionsat √s = 900 GeV with ALICE at the LHC

46. Production of pions, kaons and protons in pp collisions√s = 900 gev with Alice at the lhc

47. Production of pions, kaons and protons in pp collisions at root s=900 GeV with ALICE at the LHC

48. C1* - Trends in the choice of first line treatment for hormone - responsive (HR+), human epidermal growth factor receptor - 2 negative (HER2-) metastatic breast cancer (MBC) patients (pts): results of a multicentric Italian observational study

49. Midrapidity antiproton-to-proton ratio in pp collisions at $\sqrt{s} = 0.9$ and $7$ TeV measured by the ALICE experiment

50. Midrapidity Antiproton-to-Proton ratio in pp Collisons at sqrt s=0.9 and 7 TeV measured by the ALICE experiment

Catalog

Books, media, physical & digital resources